Topical cream for erectile dysfunction could prove safer
September 19th, 2009 - 12:25 pm ICT by ANIWashington, Sept 19 (ANI): An innovative drug-delivery system, nanoparticles encapsulating nitric oxide or prescription drugs, has shown promise for topical treatment of erectile dysfunction (ED), say New York scientists.
According to scientists at Albert Einstein College of Medicine of Yeshiva University, the new system, which was tested successfully on a small number of animals, could potentially prevent side effects associated with oral ED medications, if study results can be replicated in humans.
The study has been published in the online edition of the Journal of Sexual Medicine.
Tens of millions of men worldwide have benefited from oral ED medications such as sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis). However, these medications - which belong to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors - have limitations. They can cause systemic side effects that can be serious. These side effects include headache, facial flushing, nasal congestion, upset stomach, abnormal vision as well as isolated reports of hearing and vision loss.
In addition, “an estimated 30 to 50 percent of men with ED do not respond to oral use of PDE5 inhibitors,” says senior author Kelvin P. Davies, Ph.D., associate professor of urology at Einstein.The drug-delivery system, developed by Einstein scientists, consists of nanoparticles that can carry tiny payloads of various drugs or other medically useful substances and release them in a controlled and sustained manner.
The limited number of topical formulations of ED drugs has so far proven ineffective. The latest study was done to evaluate whether the Einstein nanoparticles, which have been shown to penetrate the skin, might allow the targeted delivery of compounds that treat ED and thereby avoid the drugs’ systemic effects.
An effective topical therapy could be especially significant for those ED patients who have reduced levels of nitric oxide (NO), the signaling molecule that dilates blood vessels responsible for erectile activity. These men, who often aren’t helped by oral PDE5 inhibitor drugs, may benefit from direct application of NO or the PDE5 inhibitors. (ANI)
- Nano drug delivery helpful in treating erectile dysfunction - Sep 19, 2009
- Viagra may cause hearing loss - May 19, 2010
- Erectile dysfunction drug could enhance delivery of herceptin to brain tumours - May 08, 2010
- Jury still out on Viagra, Levitra and Cialis championship race title - May 19, 2009
- Male sexual dysfunction drugs may some day help women also - Apr 17, 2009
- Antioxidants show promise in treating infertility - Jul 30, 2011
- Hair loss medications can affect men's sexual health - Mar 08, 2011
- Cutaneous application of nanoparticles may help treat erectile dysfunction - Apr 27, 2009
- Viagra relatives could minimize abnormally large hearts - Sep 25, 2009
- Erectile dysfunction drugs 'pose no threat to vision' - Apr 14, 2009
- Gene to sabotage breast cancer cells - Feb 28, 2011
- Popular drugs could trip sex drive - Mar 08, 2011
- Viagra may help cancer-fighting drugs reach malignant brain tumours - Jul 29, 2008
- Nanoparticles help improve survival after blood loss - Feb 23, 2011
- Injectable gel could ease crippling joint pains - Apr 14, 2011
Tags: albert einstein, albert einstein college, albert einstein college of medicine, albert einstein college of medicine of yeshiva universi, college of medicine, drug delivery system, ed patients, einstein college of medicine, facial flushing, nasal congestion, pde5 inhibitors, prescription drugs, sexual medicine, systemic effects, systemic side effects, topical cream, topical therapy, topical treatment, upset stomach, vardenafil